NCT02011087

Bioelectrical Impedance Phase Angle in Predicting Treatment Outcome in Patients With Extensive Stage Small Cell Lung Cancer Receiving First-Line Chemotherapy

Investigating the Prognostic Importance of Bioelectrical Impedance Phase Angle in Adults Treated for Small Cell Lung Cancer

• Status: Terminated
• Phase: N/A
• Study type: Interventional
• Enrollment: 1 (actual)
• Sponsor: Wake Forest University Health Sciences · Academic / Other
• Sex: All
• Age: 18 Years
• Healthy volunteers: Not accepted

Summary

This clinical trial studies bioelectrical impedance phase angle in predicting treatment outcome in patients with extensive stage small cell lung cancer receiving first-line chemotherapy. Diagnostic procedures, such as bioelectrical impedance analysis, may help predict a patient's response to treatment for small cell lung cancer.

Detailed description

PRIMARY OBJECTIVES: I. To evaluate the association between phase angle (PA) measurement and progression-free survival (PFS). SECONDARY OBJECTIVES: I. To evaluate the association between PA measurement and treatment-related outcomes of treatment response, adverse treatment events, and overall survival (OS). II. To determine the feasibility of obtaining PA measurements at a single time point in patients undergoing evaluation in thoracic oncology clinics. OUTLINE: Patients undergo bioelectrical impedance phase angle measurement on day 1 of treatment. After completion of study treatment, patients are followed up every 2-3 months for two years.

Conditions

• Extensive Stage Small Cell Lung Cancer

Interventions

Type	Name	Description
PROCEDURE	bioelectric impedance analysis	Undergo bioelectric impedance analysis

Timeline

• Start date: 2014-02-01
• Primary completion: 2016-09-01
• Completion: 2016-09-01
• First posted: 2013-12-13
• Last updated: 2018-07-05

Locations

1 site across 1 country: United States